Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Myelofibrosis
NCT02421354Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2015
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in myelofibrosis (MF), sponsored by University of Texas MD Anderson Cancer Center. Started May 2015; status: terminated.
02
Drugs
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT02421354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421354.